China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review

November 2021 | 38 pages | ID: CB91F9A0CCEEN
GlobalData

Abstracts

China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China Health Group Inc (CHG), formerly known as Venturepharm Laboratories Limited, is an investment holding company. The company’s offerings include medical services, clinical research, post-marketing clinical services and extension service for new product launch. Its therapeutic expertise spans across central nervous system, cardiovascular, respiratory, dermatology as well as HIVS and allergy among others. CHG’s clientele include pharmaceutical and biotechnology companies in Europe, North America, Asia, and Africa. It operates through subsidiaries in the UK, the US and China. CHG is headquartered in Haidian District, Beijing, China.

China Health Group Inc Key Recent Developments

Nov 09,2021: China Health Group: Supplementary announcement of COVID-19 risk of death reduced by 89%, Ritonavir associated with the Group was found to work miraculously with Pfizer's new drug
Sep 20,2021: China Health Group: Resignation of independent non-executive director
Jul 08,2021: Voluntary announcement of the latest business development of China Health Group
Apr 30,2021: China Health Group: Inside information
Mar 08,2021: China Health Group: Resignation of non-executive director and change of authorised representative

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

China Health Group Inc - Key Facts
China Health Group Inc - Key Employees
China Health Group Inc - Key Employee Biographies
China Health Group Inc - Major Products and Services
China Health Group Inc - History
China Health Group Inc - Company Statement
China Health Group Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
China Health Group Inc - Business Description
China Health Group Inc - SWOT Analysis
SWOT Analysis - Overview
China Health Group Inc - Strengths
China Health Group Inc - Weaknesses
China Health Group Inc - Opportunities
China Health Group Inc - Threats
China Health Group Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Nov 09, 2021: China Health Group: Supplementary announcement of COVID-19 risk of death reduced by 89%, Ritonavir associated with the Group was found to work miraculously with Pfizer's new drug
Sep 20, 2021: China Health Group: Resignation of independent non-executive director
Jul 08, 2021: Voluntary announcement of the latest business development of China Health Group
Apr 30, 2021: China Health Group: Inside information
Mar 08, 2021: China Health Group: Resignation of non-executive director and change of authorised representative
Feb 03, 2021: China Health Group : Voluntary announcement of the latest business development
Aug 05, 2020: China Health Group: Resignation of non executive director

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

China Health Group Inc, Key Facts
China Health Group Inc, Key Employees
China Health Group Inc, Key Employee Biographies
China Health Group Inc, Major Products and Services
China Health Group Inc, History
China Health Group Inc, Subsidiaries
China Health Group Inc, Key Competitors
China Health Group Inc, Ratios based on current share price
China Health Group Inc, Annual Ratios
China Health Group Inc, Annual Ratios (Cont...1)
China Health Group Inc, Annual Ratios (Cont...2)
China Health Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

China Health Group Inc, Performance Chart (2016 - 2020)
China Health Group Inc, Ratio Charts